INNOMOL
Enhancement of the Innovation Potential in SEE through new Molecular Solutions in Research and Development
| Coordinatore | RUDER BOSKOVIC INSTITUTE
Organization address
address: Bijenicka cesta 54 contact info |
| Nazionalità Coordinatore | Croatia [HR] |
| Totale costo | 5˙313˙649 € |
| EC contributo | 4˙738˙978 € |
| Programma | FP7-REGPOT
Specific Programme "Capacities": Research potential of Convergence Regions |
| Code Call | FP7-REGPOT-2012-2013-1 |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-06-01 - 2016-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
RUDER BOSKOVIC INSTITUTE
Organization address
address: Bijenicka cesta 54 contact info |
HR (ZAGREB) | coordinator | 4˙738˙978.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The InnoMol project will foster a research pipeline at the Rudjer Boskovic Institute (RBI) and facilitate new avenues of innovation and technology for the investigation of relevant diseases. As InnoMol goals are oriented to the future development of possible diagnostic, preventive and/or therapeutic approaches for the major diseases of the world, it is essential to have access to a center of excellence that can provide the cross-functional and project-oriented alignment of resources and expertises along the value chain leading towards an innovative product. The project will bring together and reinforce 3 major worlds of life sciences, e.g. Medicine, Biology, and Chemistry to create a productive, state-of-the-art environment that is unique in the region and will bridge the gap between the pre-commercial and commercial phases of R&D, thus enhancing the relevance of the RBI’s position in the European Research Area (ERA). The fully assembled research pipeline will enable inter- and, multidisciplinary research in the field of Molecular Biosciences with focus on DNA-Protein, Protein-Protein, Protein-RNA, DNA-RNA and DNA-DNA interactions. The tangible outcomes of the Action will be innovative molecular solutions for investigating major global diseases in order to transfer the knowledge to the community for the generation of wealth and public wellbeing.'